Nakajima, Shinichiro
Keio University
7 papers on CoChatORCID 0000-0002-2601-2195
Most cited papers
- Verified
Gut microbiota and major depressive disorder: a systematic review and meta-analysis
Sanada, K., Nakajima, S., Kurokawa, S., Barceló-Soler, A., Ikuse, D., Hirata, A., Yoshizawa, A., Tomizawa, Y., Salas-Valero, M., Noda, Y., et al. (2020) · Journal of Affective Disorders
Gut microbiota and healthProbiotics and Fermented Foods
Cited by 372
- Verified
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Moriguchi, S., Takamiya, A., Noda, Y., Horita, N., Wada, M., Tsugawa, S., Plitman, E., Sano, Y., Tarumi, R., ElSalhy, M., et al. (2019) · Molecular Psychiatry
Treatment of Major DepressionAdvanced MRI Techniques and Applications
Cited by 357
- Verified
Kynurenine pathway in depression: a systematic review and meta-analysis
Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., Wada, M., Tarumi, R., Plitman, E., Moriguchi, S., et al. (2018) · Neuroscience & Biobehavioral Reviews
Tryptophan and brain disordersTreatment of Major Depression
Cited by 301
- Verified
Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer's disease: A systematic review
Iimori, T., Nakajima, S., Miyazaki, T., Tarumi, R., Ogyu, K., Wada, M., Tsugawa, S., Masuda, F., Daskalakis, Z. J., Blumberger, D. M., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Transcranial Magnetic Stimulation StudiesElectroconvulsive Therapy Studies
Cited by 94
- Verified
Corticotropin-releasing hormone and dopamine release in healthy individuals
Payer, D., Williams, B., Mansouri, E., Stevanovski, S., Nakajima, S., Le Foll, B., Kish, S., Houle, S., Mizrahi, R., George, S. R., et al. (2017) · Psychoneuroendocrinology
Stress Responses and CortisolNeurotransmitter Receptor Influence on Behavior
Cited by 26
- Verified
Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease
Kobayashi, N., Shinagawa, S., Niimura, H., Kida, H., Nagata, T., Tagai, K., Shimada, K., Oka, N., Shikimoto, R., Noda, Y., et al. (2020) · Scientific Reports
Dementia and Cognitive Impairment ResearchEpigenetics and DNA Methylation
Cited by 23
- Verified
Pharmacotherapeutic combinations for the treatment of Alzheimer’s disease.
Nagata, T., Shinagawa, S., Nakajima, S., Noda, Y., & Mimura, M. (2022) · Expert Opinion on Pharmacotherapy
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 11
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free